{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:24:17Z","timestamp":1794230657290,"version":"4.9.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tjpad.2026.100664","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:40:00Z","timestamp":1787924400000},"page":"100664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-1773","authenticated-orcid":false,"given":"Moeko","family":"Noguchi-Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5971-4538","authenticated-orcid":false,"given":"Daiki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-3999","authenticated-orcid":false,"given":"Yasuhiro","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5337-4942","authenticated-orcid":false,"given":"Yasutake","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-6322","authenticated-orcid":false,"given":"Junji","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-0444","authenticated-orcid":false,"given":"Tokuhei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-6155","authenticated-orcid":false,"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2026.100664_bib0001","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1021\/acs.nanolett.3c00187","article-title":"Structural dynamics of amyloid-\u03b2 protofibrils and actions of anti-amyloid-\u03b2 antibodies as observed by high-speed atomic force microscopy","volume":"23","author":"Watanabe-Nakayama","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.tjpad.2026.100664_bib0002","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ana.27175","article-title":"Lecanemab-associated amyloid-\u03b2 protofibril in cerebrospinal fluid correlates with biomarkers of neurodegeneration in Alzheimer\u2019s disease","volume":"97","author":"Noguchi-Shinohara","year":"2025","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2026.100664_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2026.100664_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2169\/internalmedicine.4569-24","article-title":"The basis of Anti-a\u03b2 antibody therapy: the toxicity of a\u03b2 aggregates and the mechanism of action of anti-a\u03b2 antibodies","volume":"65","author":"Ono","year":"2026","journal-title":"Intern Med"},{"key":"10.1016\/j.tjpad.2026.100664_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2169\/internalmedicine.4604-24","article-title":"Anti-amyloid \u03b2 antibody therapies for Alzheimer\u2019s Disease: association between the target of amyloid \u03b2 aggregates and the Clinical efficacy of Anti-amyloid \u03b2 antibody","volume":"65","author":"Noguchi-Shinohara","year":"2026","journal-title":"Intern Med"},{"key":"10.1016\/j.tjpad.2026.100664_bib0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13195-025-01912-6","article-title":"Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data","volume":"17","author":"Noguchi-Shinohara","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2026.100664_bib0007","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jamaneurol.2025.1232","article-title":"Lecanemab treatment in a specialty memory clinic","volume":"82","author":"Paczynski","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100664_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2026.100489","article-title":"Lecanemab over a two-year duration: key insights from a regional specialty medical center","volume":"13","author":"Shields","year":"2026","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2026.100664_bib0009","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00415-025-13142-9","article-title":"Monoclonal antibody administration in an academic institution and private neurological practice: a tale of two clinics","volume":"272","author":"Rosenbloom","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100664_bib0010","article-title":"Real-world experience with lecanemab therapy for Alzheimer\u2019s disease in the Intermountain West","volume":"18","author":"Curd","year":"2026","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"10.1016\/j.tjpad.2026.100664_bib0011","unstructured":"Guidelines for promoting optimal use for lecanemab: Suppression of progression of mild cognitive impairment and mild dementia due to Alzheimer\u2019s disease. https:\/\/www.pmda.go.jp\/files\/000265885.pdf 19-Feb 2026 accessed."},{"key":"10.1016\/j.tjpad.2026.100664_bib0012","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0167-4943(91)90053-S","article-title":"Measurement of competence: reliability and validity of the TMIG Index of Competence","volume":"13","author":"Koyano","year":"1991","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.tjpad.2026.100664_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.tjpad.2026.100664_bib0014","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use reccomendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimer Dis"},{"key":"10.1016\/j.tjpad.2026.100664_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12149-022-01769-x","article-title":"Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer\u2019s disease","volume":"36","author":"Imabayashi","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.tjpad.2026.100664_bib0016","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cen3.12821","article-title":"Amyloid-related imaging abnormalities in a woman with apolipoprotein E\u03b54 homozygotes treated with lecanemab for Alzheimer\u2019s disease","volume":"16","author":"Noguchi-Shinohara","year":"2025","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.tjpad.2026.100664_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100160","article-title":"Clarity AD: asian regional analysis of a phase III trial of lecanemab in early Alzheimer\u2019s disease","volume":"12","author":"Chen","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2026.100664_bib0018","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.tjpad.2026.100664_bib0019","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.3390\/ijms25147543","article-title":"Associations between microglia and astrocytic proteins and tau biomarkers across the continuum of Alzheimer\u2019s disease","volume":"25","author":"Doroszkiewicz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjpad.2026.100664_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/alz.13450","article-title":"Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression","volume":"20","author":"Pelkmans","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100664_bib0021","article-title":"Long-term safety and efficacy of lecanemab in early Alzheimer\u2019s disease: results from the clarity AD open-label extension study","volume":"21","author":"van Dyck","year":"2025","journal-title":"Alzheimers Dement"}],"updated-by":[{"DOI":"10.1016\/j.tjpad.2026.100668","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:25:45Z","timestamp":1794227145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2274580726001883"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100664","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100664"}}